HGM Limited Acquires 100% Stake in Aidéo Technologies to Boost AI-Powered Healthcare Platform
K N Mishra
20/Aug/2025
What's covered under the Article:
-
HGM Limited Board approves acquisition of 100% equity of Aidéo Technologies LLC through its wholly owned subsidiary Healthcare Capital Holdings LLC.
-
Acquisition involves issuance of HCH Class B Preferred Stock valued at Rs. 14.08 Crores, making Aidéo an indirect fully owned subsidiary of HGM Limited.
-
Aidéo Technologies’ AI-powered Autonomous Coding Platform enhances HGM’s healthcare services, supporting RCM, EHR interoperability, and operational scalability in the U.S.
HGM Limited (formerly HOV Services Limited), a global technology-driven enterprise, has taken a major strategic step by acquiring 100% equity stake in Aidéo Technologies LLC, a U.S.-based leader in AI-powered Autonomous Medical Coding solutions. This decision was approved at the Board meeting held on August 20, 2025, following the recommendation of the Audit Committee. The acquisition is executed through HGM’s wholly owned U.S. subsidiary, Healthcare Capital Holdings LLC (HCH), via issuance of Class B Preferred Stock valued at Rs. 14.08 Crores, making Aidéo an indirect fully owned subsidiary of HGM.
Aidéo Technologies LLC, headquartered at Las Vegas, Nevada, is a leading provider of AI-driven autonomous coding productivity solutions for the Revenue Cycle Management (RCM) industry. Established on November 2, 2009, Aidéo has demonstrated consistent growth with turnovers of INR 7.44 Crores (FY22), INR 11.70 Crores (FY23), and INR 18.96 Crores (FY24). Its Gemini™ AI Coding Platform leverages advanced AI, Large Language Models (LLM), natural language processing, and real-time analytics to enhance medical coding accuracy, speed, and cost efficiency, surpassing traditional computer-assisted coding (CAC) tools. The platform ensures HL7 interoperability, enabling seamless integration with electronic health records (EHR) across surgical specialties, anesthesia, radiology, emergency departments, and RCM companies throughout the U.S.
This acquisition aligns perfectly with HGM Limited’s strategic vision to build a comprehensive AI-driven healthcare services platform. By integrating Aidéo’s AI-powered coding capabilities, HGM aims to scale operations rapidly, enhance compliance, and deliver measurable value to providers, payers, and patients. The deal also strengthens HGM’s offerings in medical coding, revenue cycle management, and healthcare analytics, reinforcing its position as a category-leading technology-driven enterprise in the healthcare sector.
The transaction has been structured at arm’s length and does not fall under related party transactions. Post-acquisition, Aidéo will become a related party, but the process ensures full compliance with applicable laws, statutory approvals, consents, and permissions. Since the acquisition is made through HCH, no prior governmental approvals are required. The Board of HGM Limited expects the transaction to complete on August 20, 2025, subject to customary closing conditions.
Management Commentary: Dr. Bhargav Thakkar, EVP Healthcare of HGM Limited, emphasized that acquiring Aidéo Technologies is a milestone in building an AI-driven healthcare platform. He highlighted that the Autonomous Coding Platform delivers superior accuracy compared to manual coding methods and traditional CAC tools. By integrating this AI-led automation into critical healthcare workflows, HGM aims to meet the growing demand for efficiency, innovation, and compliance within the healthcare ecosystem.
HGM Limited, leveraging its strengths in Artificial Intelligence, operational scalability, and process excellence, continues to focus on building scalable solutions in high-growth sectors. The addition of Aidéo Technologies LLC enhances its technological capabilities, particularly in areas such as medical coding productivity, revenue cycle management, and healthcare analytics. This strategic acquisition positions HGM to offer AI-led automation to healthcare providers and RCM companies, helping them reduce costs, improve operational efficiency, and ensure regulatory compliance.
The acquisition represents a key milestone in HGM Limited’s growth trajectory, reinforcing its commitment to innovation and technology-led healthcare solutions. Aidéo’s expertise in AI, LLM-based coding, and real-time analytics complements HGM’s existing operations, enabling the Company to expand rapidly in the U.S. healthcare market. Additionally, this transaction is expected to enhance shareholder value, reflecting HGM’s focus on strategic expansion and long-term growth.
In summary, the acquisition of Aidéo Technologies LLC by HGM Limited through Healthcare Capital Holdings LLC strengthens HGM’s AI-driven healthcare services platform, enhances its revenue cycle management capabilities, and provides a scalable solution for autonomous medical coding. This strategic move underscores HGM’s focus on technology-led innovation, operational efficiency, and compliance, positioning the Company as a market leader in AI-powered healthcare solutions.
With this acquisition, HGM Limited continues to demonstrate its commitment to transforming healthcare services through advanced AI-driven technology, expanding its footprint, and delivering measurable outcomes for providers, payers, and patients across the United States.
The Upcoming IPOs in this week and coming weeks are NIS Management, Sattva Engineering Construction, Globtier Infotech, Current Infraprojects, Anondita Medicare, Classic Electrodes (India), Vikran Engineering, Shivashrit Foods, ARC Insulation & Insulators.
The Current active IPO are Mangal Electrical Industries, LGT Business Connextions, Vikram Solar, Gem Aromatics, Shreeji Shipping Global, Patel Retail, Studio LSD.
Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.
Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.
Related News
Disclaimer
The information provided on this website is for educational and informational purposes only and should not be considered as financial advice, investment advice, or trading recommendations.
Trading in stocks, forex, commodities, cryptocurrencies, or any other financial instruments involves high risk and may not be suitable for all investors. Prices can fluctuate rapidly, and there is a possibility of losing part or all of your invested capital.
We do not guarantee any profits, returns, or outcomes from the use of our website, services, or tools. Past performance is not indicative of future results.You are solely responsible for your investment and trading decisions. Before making any financial commitment, it is strongly recommended to consult with a qualified financial advisor or do your own research.
By accessing or using this website, you acknowledge that you have read, understood, and agree to this disclaimer. The website owners, partners, or affiliates shall not be held liable for any direct or indirect loss or damage arising from the use of information, tools, or services provided here.